Immunosuppressant Drugs: Required Labeling Changes – stronger warnings about the risk of BK virus-associated nephropathy July 14 Pogust Millrood Pharmaceuticals FDA: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm171828.htm